November 2008
Pharmaceutical Technology Europe;Nov2008, Vol. 20 Issue 11, p65
Trade Publication
The article reports on the significance of the forward-thinking reputation, well-funded research universities and world leadership in stem cell research and green energy in assuring continued business operation of biotechnology companies in California in 2008. Continued financial support for research and development projects in universities and colleges offer companies more progressive and positive business operation.


Related Articles

  • ITI Life Science Launches £9.5 Million Stem Cell Program.  // BioPharm International;Mar2007, Vol. 20 Issue 3, p20 

    The article announces the launching of a £9.5 million R&D program by ITI Life Sciences in Dundee, Scotland. The program was undertaken to develop an automated process in the production of high-quality human stem cells. As part of the three-year program, Cellartis AB, a Swedish stem cell...

  • In Fate's Hands. Chambers, Heather // San Diego Business Journal;2/23/2009, Vol. 30 Issue 8, p1 

    The article reports on the entry of Fate Therapeutics into the biotechnology industry in California with $22.5 million raised. This local startup assembled a team of internationally recognized scientists from among the best universities such as Harvard and Stanford Universities. Fate co-founder...

  • Industry concerns mount over CIRM grants. Baker, Monya // Nature Biotechnology;Oct2007, Vol. 25 Issue 10, p1063 

    The article focuses on the grants offered by the California Institute of Regenerative Medicine (CIRM) to biotechnology organizations involved in stem cell research in the state of California. The companies receiving the grants are required to share revenues by informing about patent applications...

  • Adult stem cell research surges ahead.  // Indianapolis Business Journal;8/16/2010, Vol. 31 Issue 24, p20 

    The article reports on the increasing interest of researchers to focus their endeavors on adult stem cell research.

  • Stern cell scientists call for open process for reviewing research. Mayor, Susan // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/13/2010, Vol. 340 Issue 7742, p335 

    The article focuses on the claim of stem cell researchers that reviewers might be hindering the publication of high quality research.

  • FROM THE EDITORS.  // APA Newsletters;Fall2008, Vol. 8 Issue 1, Special section p1 

    The article discusses various reports published within the issue including one about the conflict between scientific progress and political process and another on a proposed bill concerning the mediation of the social turmoil surrounding stem cell research.

  • The Vatican, University of Maryland enter into adult stem cell research partnership to study intestinal and other diseases.  // Transplant News;May2010, Vol. 20 Issue 5, p11 

    The article reports on the announcement of the Vatican and the University of Maryland School of Medicine regarding their partnership to study the use adult stem cells in the treatment of intestinal and other diseases.

  • Access to human embryonic stem cell lines. Levine, Aaron D // Nature Biotechnology;Dec2011, Vol. 29 Issue 12, p1079 

    The article discusses a study that assessed the importance of access concerns in the development of human embryonic stem cell (hESC) science. It highlights the results of a survey of stem cell scientists in the U.S. on the specific hESC lines they use and their experiences acquiring the lines....

  • Appeals Court Action Hailed by BIO.  // Chain Drug Review;9/27/2010, Vol. 32 Issue 16, p89 

    The article reports on Biotechnology Industry Organization's (BIO) re-emphasis on its support of stem cell research in the U.S.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics